Jason S. Slakter, MD.AMD SCIENTIFIC ADVISORY BOARD
Vitreous Retina Macular Consultants of New York and Clinical Professor of Ophthalmology, New York University School of Medicine, USA
Dr. Jason Slakter is a board certified retinal and macular disease specialist, Clinical Professor of Ophthalmology at New York University School of Medicine, and partner at Vitreous-Retina-Macula Consultants of New York. Dr. Slakter was one of the co-founders of SKS Ocular, which was acquired by Ohr in June of 2014. He joined Ohr Pharmaceuticals as Chief Medical Officer upon closing of the transaction. As of January 2015, Dr. Slakter is a member of the Board of Directors of Ohr Pharmaceuticals. Dr. Slakter is a member of numerous medical organizations including The Macula Society, The Retina Society, The American Society of Retina Specialists, and the New York Ophthalmological Society. He is the Editor–in–Chief of Retinal Physician and is on the editorial board of the journal Retina. He has been the recipient of many awards including The Macula Society’s Richard and Hinda Rosenthal Award for outstanding contribution to the treatment of ocular disease by an individual under the age of 45, as well as the Helen Keller Manhattan League Award in 2003. Dr. Slakter has published more than 100 papers and book chapters.
Dr. Slakter’s chief research interests relate to the management of exudative age-related macular degeneration, retinal vascular disease, and central serous chorioretinopathy. He created and is the director of the Digital Angiography Reading Center (DARC), which is one of the largest centers for image evaluation for clinical trials of posterior segment disease with over 900 certified clinical sites in over 44 countries worldwide, serving as a key resource for industry-sponsored studies of new treatments for retinal disorders.